J&J's vaccine implementation study in South Africa gets regulator nod

South Africa's drugs regulator said on Monday it had approved an implementation study of Johnson & Johnson's COVID-19 vaccine, clearing the way to start the country's first inoculations among frontline health workers.
 

South Africa has yet to launch its Covid-19 vaccination programme and the government has decided to go with the J&J dose after trial results this month showed AstraZeneca's two-shot vaccine was less effective against the new variant of the coronavirus dominating South African infections.
 

"SAHPRA has approved the implementation study," the regulator said in response to Reuters questions, adding it was still reviewing its separate application for full